Thomas Del'Guidice

Years Active: 2018-2019
Publications (10 Years): 2

Feldan Therapeutics

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Feldan Therapeutics Nov 01 2013

Canada

Project Manager, Scientist and MBA candidate

Publications

Sateesh Krishnamurthy, Christine Wohlford-Lenane, Suhas Kandimalla, Gilles Sartre, David K Meyerholz, Vanessa Théberge, Stéphanie Hallée, Anne-Marie Duperré, Thomas Del'Guidice, Jean-Pascal Lepetit-Stoffaes, Xavier Barbeau, David Guay, Paul B McCray
Engineered amphiphilic peptides enable delivery of proteins and CRISPR-associated nucleases to airway epithelia. Nature communications 10 (1) (2019)
Thomas Del'Guidice, Jean-Pascal Lepetit-Stoffaes, Louis-Jean Bordeleau, Joannie Roberge, Vanessa Théberge, Coraline Lauvaux, Xavier Barbeau, Jessica Trottier, Vibhuti Dave, Denis-Claude Roy, Bruno Gaillet, Alain Garnier, David Guay
Membrane permeabilizing amphiphilic peptide delivers recombinant transcription factor and CRISPR-Cas9/Cpf1 ribonucleoproteins in hard-to-modify cells. PloS one 13 (4) (2018)

Thomas Del'Guidice.css-eqlu8i{font-size:small;padding-left:4px;}